Cancer Vaccines 2017: Overcoming hurdles to cancer immune response: Cell therapies, vaccine development, and combination therapies.
Join us this September for strategic direction on vaccine commercialisation to provide you with the key requirements and tools for successful vaccine development and combination therapies through informed guidance delivered by a top panel of speakers including Vaccinogen, MSD, Genentech, Northwest Biotherapeutics, and more!
Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2017 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 6th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalized treatment, immune check-point inhibitors and much more!
This content is blocked. Accept cookies to view the content.